The Burbs Police Department
Burbs Code Reference
O.C.B.A. § 16-13-29
Schedule V.
Title 16. Crimes and Offenses · Chapter 13. Controlled Substances · Article 2. Regulation of Controlled Substances · Part 1. Schedules, Offenses, and Penalties
Statutory text
The controlled substances listed in this Code section are included in Schedule V:
(1) Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or salts thereof, which also contains one or more nonnarcotic, active, medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
(A) Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams;
(B) Not more than 100 milligrams of dihydrocodeine, or any of its salts, per 100 milliliters or per 100 grams;
(C) Not more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or per 100 grams;
(D) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;
(E) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
(1.25) Cenobamate, including its salts;
(1.5) Ganaxolone;
(2) Lacosamide;
(3) Pregabalin;
(4) Pyrovalerone;
(5) Pseudoephedrine as an exempt over-the-counter Schedule V controlled substance distributed in the same manner as set forth in Code Section 16-13-29.2; provided, however, that such exemption shall take effect immediately and shall not require rule making by the State Board of Pharmacy; provided, further, that wholesale drug distributors located within this state and licensed by the State Board of Pharmacy and which are registered and regulated by the DEA shall not be subject to any board requirements for controlled substances for the storage, reporting, record keeping, or physical security of drug products containing pseudoephedrine which are more stringent than those included in DEA regulations;
(6) Ezogabine;
(7) Brivaracetam; or
(8) Lasmiditan, including its salts, isomers, and salts of isomers.
- Source
- V14B · 2024, page 299–301. Including Acts of the 2025 Regular Session of the General Assembly. Official source PDF (legis.ga.gov)
- Version
- Edition ocga-2025-supplement-v3 · Matched to source
- History
- Code 1933, § 79A-810, enacted by Ga. L. 1974, p. 221, § 1; Ga. L. 1978, p. 1668, § 9; Ga. L. 1979, p. 859, § 9; Ga. L. 1980, p. 1746, § 8; Ga. L. 1981, p. 557, § 5; Ga. L. 1984, p. 1019, § 2; Ga. L. 1986, p. 1555, § 5; Ga. L. 1989, p. 233, § 5; Ga. L. 1993, p. 590, § 3; Ga. L. 2003, p. 349, § 5; Ga. L. 2007, p. 605, § 2/HB 286; Ga. L. 2010, p. 860, § 4/SB 353; Ga. L. 2011, p. 656, § 6/SB 93; Ga. L. 2012, p. 40, § 4/SB 370; Ga. L. 2015, p. 5, § 16/HB 90; Ga. L. 2017, p. 14, § 8/HB 231; Ga. L. 2019, p. 820, § 3/HB 483; Ga. L. 2020, p. 493, § 16/SB 429; Ga. L. 2021, p. 184, § 27/SB 195; Ga. L. 2021, p. 386, § 7/HB 367; Ga. L. 2023, p. 137, § 4/HB 332, effective May 1, 2023.
- Amendment notes (editorial)
- The 2023 amendment, effective May 1, 2023, substituted “Ganaxolone” for “Reserved” in paragraph (1.5).
- Editor's notes (editorial)
- Ga. L. 2012, p. 40, § 1/SB 370, not codified by the General Assembly, which provides for the annual update of the identity of controlled substances and dangerous drugs, is dedicated to the memory of Chase Corbitt Burnett and shall be known and may be cited as “Chase’s Law.” Ga. L. 2021, p. 184, § 28/SB 195, not codified by the General Assembly, provides that: “Nothing in this Act shall be deemed to change, amend, or alter any criteria for applications for a Class 1 or Class 2 production license submitted to The Burbs Access to Medical Cannabis Commission on or prior to January 27, 2021.”
